278 related articles for article (PubMed ID: 35792918)
1. Interactive effects of polygenic risk and cognitive subtype on brain morphology in schizophrenia spectrum and bipolar disorders.
Quidé Y; Watkeys OJ; Girshkin L; Kaur M; Carr VJ; Cairns MJ; Green MJ
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1205-1218. PubMed ID: 35792918
[TBL] [Abstract][Full Text] [Related]
2. Distinct Associations of Cognitive Impairments and Reduced Gray Matter Volumes in Remitted Patients with Schizophrenia and Bipolar Disorder.
Sun T; Zhao P; Jiang X; Zhou Y; Li C; Jia L; Tang Y
Neural Plast; 2020; 2020():8859388. PubMed ID: 33381163
[TBL] [Abstract][Full Text] [Related]
3. Shared and distinct gray matter abnormalities in schizophrenia, schizophrenia relatives and bipolar disorder in association with cognitive impairment.
Knöchel C; Stäblein M; Prvulovic D; Ghinea D; Wenzler S; Pantel J; Alves G; Linden DE; Harrison O; Carvalho A; Reif A; Oertel-Knöchel V
Schizophr Res; 2016 Mar; 171(1-3):140-8. PubMed ID: 26833265
[TBL] [Abstract][Full Text] [Related]
4. Polygenic risk scores distinguish patients from non-affected adult relatives and from normal controls in schizophrenia and bipolar disorder multi-affected kindreds.
Boies S; Mérette C; Paccalet T; Maziade M; Bureau A
Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):329-336. PubMed ID: 29193655
[TBL] [Abstract][Full Text] [Related]
5. Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study.
Rodriguez V; Alameda L; Quattrone D; Tripoli G; Gayer-Anderson C; Spinazzola E; Trotta G; Jongsma HE; Stilo S; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; Bonora E; Jamain S; Selten JP; Velthorst E; de Haan L; Llorca PM; Arrojo M; Bobes J; Bernardo M; Arango C; Kirkbride J; Jones PB; Rutten BP; Richards A; Sham PC; O'Donovan M; Van Os J; Morgan C; Di Forti M; Murray RM; Vassos E
Psychol Med; 2023 Jun; 53(8):3396-3405. PubMed ID: 35076361
[TBL] [Abstract][Full Text] [Related]
6. Shared intermediate phenotypes for schizophrenia and bipolar disorder: neuroanatomical features of subtypes distinguished by executive dysfunction.
Shepherd AM; Quidé Y; Laurens KR; O'Reilly N; Rowland JE; Mitchell PB; Carr VJ; Green MJ
J Psychiatry Neurosci; 2015 Jan; 40(1):58-68. PubMed ID: 25268788
[TBL] [Abstract][Full Text] [Related]
7. Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study.
Maggioni E; Crespo-Facorro B; Nenadic I; Benedetti F; Gaser C; Sauer H; Roiz-Santiañez R; Poletti S; Marinelli V; Bellani M; Perlini C; Ruggeri M; Altamura AC; Diwadkar VA; Brambilla P;
PLoS One; 2017; 12(11):e0188000. PubMed ID: 29136642
[TBL] [Abstract][Full Text] [Related]
8. Factor analysis of lifetime psychopathology and its brain morphometric and genetic correlates in a transdiagnostic sample.
Krug A; Stein F; David FS; Schmitt S; Brosch K; Pfarr JK; Ringwald KG; Meller T; Thomas-Odenthal F; Meinert S; Thiel K; Winter A; Waltemate L; Lemke H; Grotegerd D; Opel N; Repple J; Hahn T; Streit F; Witt SH; Rietschel M; Andlauer TFM; Nöthen MM; Philipsen A; Nenadić I; Dannlowski U; Kircher T; Forstner AJ
Transl Psychiatry; 2024 Jun; 14(1):235. PubMed ID: 38830892
[TBL] [Abstract][Full Text] [Related]
9. Schizophrenia polygenic risk score influence on white matter microstructure.
Simões B; Vassos E; Shergill S; McDonald C; Toulopoulou T; Kalidindi S; Kane F; Murray R; Bramon E; Ferreira H; Prata D
J Psychiatr Res; 2020 Feb; 121():62-67. PubMed ID: 31770658
[TBL] [Abstract][Full Text] [Related]
10. Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder.
Markota M; Coombes BJ; Larrabee BR; McElroy SL; Bond DJ; Veldic M; Colby CL; Chauhan M; Cuellar-Barboza AB; Fuentes M; Kung S; Prieto ML; Rummans TA; Bobo WV; Frye MA; Biernacka JM
Transl Psychiatry; 2018 Sep; 8(1):188. PubMed ID: 30201969
[TBL] [Abstract][Full Text] [Related]
11. Structural brain morphometry associated with theory of mind in bipolar disorder and schizophrenia.
Quidé Y; Wilhelmi C; Green MJ
Psych J; 2020 Apr; 9(2):234-246. PubMed ID: 31773921
[TBL] [Abstract][Full Text] [Related]
12. Investigating associations between genetic risk for bipolar disorder and cognitive functioning in childhood.
Mistry S; Escott-Price V; Florio AD; Smith DJ; Zammit S
J Affect Disord; 2019 Dec; 259():112-120. PubMed ID: 31445336
[TBL] [Abstract][Full Text] [Related]
13. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
[TBL] [Abstract][Full Text] [Related]
14. Association of polygenic risk for bipolar disorder with grey matter structure and white matter integrity in youth.
Jiang X; Zai CC; Kennedy KG; Zou Y; Nikolova YS; Felsky D; Young LT; MacIntosh BJ; Goldstein BI
Transl Psychiatry; 2023 Oct; 13(1):322. PubMed ID: 37852985
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder.
Ohi K; Shimada M; Soda M; Nishizawa D; Fujikane D; Takai K; Kuramitsu A; Muto Y; Sugiyama S; Hasegawa J; Kitaichi K; Ikeda K; Shioiri T
BMJ Ment Health; 2024 Jan; 27(1):. PubMed ID: 38216218
[TBL] [Abstract][Full Text] [Related]
16. Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, and schizophrenia spectrum disorders.
David FS; Stein F; Andlauer TFM; Streit F; Witt SH; Herms S; Hoffmann P; Heilmann-Heimbach S; Opel N; Repple J; Jansen A; Nenadić I; Papiol S; Heilbronner U; Kalman JL; Schaupp SK; Senner F; Schulte EC; Falkai PG; Schulze TG; Dannlowski U; Kircher T; Rietschel M; Nöthen MM; Krug A; Forstner AJ
Schizophr Res; 2023 Feb; 252():161-171. PubMed ID: 36652833
[TBL] [Abstract][Full Text] [Related]
17. Genome-Transcriptome-Functional Connectivity-Cognition Link Differentiates Schizophrenia From Bipolar Disorder.
Chen J; Fu Z; Bustillo JR; Perrone-Bizzozero NI; Lin D; Canive J; Pearlson GD; Stephen JM; Mayer AR; Potkin SG; van Erp TGM; Kochunov P; Elliot Hong L; Adhikari BM; Andreassen OA; Agartz I; Westlye LT; Sui J; Du Y; Macciardi F; Hanlon FM; Jung RE; Turner JA; Liu J; Calhoun VD
Schizophr Bull; 2022 Nov; 48(6):1306-1317. PubMed ID: 35988022
[TBL] [Abstract][Full Text] [Related]
18. Polygenic risk score and the psychosis continuum model.
Tesli M; Espeseth T; Bettella F; Mattingsdal M; Aas M; Melle I; Djurovic S; Andreassen OA
Acta Psychiatr Scand; 2014 Oct; 130(4):311-7. PubMed ID: 24961959
[TBL] [Abstract][Full Text] [Related]
19. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
Ohi K; Nishizawa D; Sugiyama S; Takai K; Fujikane D; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
Psychol Med; 2023 Jul; 53(10):4454-4463. PubMed ID: 35971752
[TBL] [Abstract][Full Text] [Related]
20. Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity.
Quidé Y; Bortolasci CC; Spolding B; Kidnapillai S; Watkeys OJ; Cohen-Woods S; Carr VJ; Berk M; Walder K; Green MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110013. PubMed ID: 32540496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
